• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.05% Nasdaq Down 0.18%

    Keryx Biopharmaceuticals Inc. (KERX)

    -NasdaqCM
    5.29 Up 0.08(1.54%) 4:00PM EDT
    Prev Close:5.21
    Open:5.27
    Bid:5.21 x 100
    Ask:5.51 x 600
    1y Target Est:8.15
    Beta:3.04503
    Earnings Date:Aug 3 - Aug 8 (Est.)
    Day's Range:5.12 - 5.39
    52wk Range:2.80 - 11.12
    Volume:1,126,905
    Avg Vol (3m):1,839,880
    Market Cap:559.79M
    P/E (ttm):N/A
    EPS (ttm):-1.19
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    KERXUp 1.54%559.79M
    BAXUp 0.40%24.92B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):40.32
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-16) :-0.93
    Quarterly EPS Est (Jun-16) :-0.27
    Mean Recommendation*:2.4
    PEG Ratio (5 yr expected):-0.05

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Keryx Biopharmaceuticals, Inc., a biopharmaceutical company, focuses on providing therapies for patients with renal disease in the United States. Its lead product Auryxia (ferric citrate), an oral, ferric iron-based compound that has the capacity ... View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback